Medical Imaging Data Marketplace
The Advanced Research Projects Agency for Health (ARPA-H) and the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) together explored the development of a medical imaging data marketplace (MIDM) to expedite innovation in Software as a Medical Device (SaMD) and other artificial intelligence (AI)/machine learning (ML)-enabled medical devices.
In support of this effort, the Investor Catalyst Hub issued a network survey to collect feedback about specific needs and challenges that medical imaging software and product developers, users of AI and ML medical imaging products, and private and public organizations face with utilizing, managing, and producing data for product development and evaluation.
The deadline to provide survey feedback was April 16, 2024. The Investor Catalyst Hub aggregated and synthesized the results of the data into a report that may inform the model and strategy used for an MIDM and prioritize the types of data it should support. The report will also help to develop a viable economic model to ensure the long-term sustainability of the marketplace.
Who Was Invited To Respond?
This network survey sought to collect feedback from three groups:
- Medical imaging data users: Researchers (academic or private-sector) who need/use medical imaging data to train and test AI/ML models.
- Medical imaging data managers: Entities that manage, sell, or aggregate medical imaging data for researchers.
- Medical imaging data providers: Entities that create the medical imaging data needed by data users.
For more detailed definitions and examples of each group, read the network survey description.